Simplex Trading
FBRX

Simplex Trading’s Forte Biosciences FBRX Stock Holding History

Simplex Trading’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,312
Closed -$54.8K – 9578
2026
Q1 		$59.9K Sell
2,312
-3,703
-62% -$107K ﹤0.01% 5672
2025
Q4 		$164K Buy
+6,015
New +$105K ﹤0.01% 4438
2023
Q3 		– Sell
-54
Closed -$1.2K – 8981
2023
Q2 		$1K Buy
+54
New +$1.4K ﹤0.01% 8611
2020
Q2 		– Sell
-2
Closed -$894 – 7804
2020
Q1 		$0 Sell
2
-6
-75% -$2.35K ﹤0.01% 7765
2019
Q4 		$1K Sell
8
-2
-20% -$453 ﹤0.01% 7088
2019
Q3 		$2K Sell
10
-7
-41% -$10.6K ﹤0.01% 6912
2019
Q2 		$41K Sell
17
-29
-63% -$86K ﹤0.01% 5029
2019
Q1 		$187K Buy
46
+35
+318% +$135K ﹤0.01% 3695
2018
Q4 		$33K Buy
11
+7
+175% +$30.1K ﹤0.01% 4925
2018
Q3 		$22K Buy
+4
New +$15.2K ﹤0.01% 5871
2018
Q1 		– Sell
-2
Closed -$9.26K – 6336
2017
Q4 		$9K Buy
+2
New +$7.98K ﹤0.01% 3984

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Simplex Trading's FBRX Position: Q2 2026 in Review

Simplex Trading sold out of Forte Biosciences (FBRX) in Q2 2026, closing a stake of 2,312 shares — an estimated $54.8K sold.

Simplex Trading first reported a position in FBRX in Q4 2017 and held it in 11 quarters. The position peaked at $187K in Q1 2019. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Simplex Trading reported no remaining Forte Biosciences position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 2,312 Forte Biosciences shares in Q2 2026, an estimated $54.8K.
  • Simplex Trading first reported a position in Forte Biosciences in Q4 2017 and held it in 11 quarters.
  • Simplex Trading's Forte Biosciences position peaked at $187K in Q1 2019.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.